New guidelines on good distribution practices for biologics will have a significant impact on the Indian pharma sector — for good or ill. Jane Wan reports.
After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback, writes Jane Wan.
China's drug-distribution network has been a mess for years, but reforms are unveiling new opportunities for market order and growth, writes Jane Wan.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva